Girard Partners’s Prothena Corp PRTA Stock Holding History

Girard Partners’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-514	Closed	-$6K	–	666
2018 Q3	$6K	Buy	+514	New	+$7.42K	﹤0.01%	823

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Girard Partners's PRTA Position: Q4 2018 in Review

Girard Partners sold out of Prothena Corp (PRTA) in Q4 2018, closing a stake of 514 shares — an estimated $6K sold.

Girard Partners first reported a position in PRTA in Q3 2018 and held it in 1 quarter. The position peaked at $6K in Q3 2018. 120 funds tracked by Wall St. Rank hold PRTA as of Q4 2018.

Girard Partners reported no remaining Prothena Corp position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 514 Prothena Corp shares in Q4 2018, an estimated $6K.
Girard Partners first reported a position in Prothena Corp in Q3 2018 and held it in 1 quarter.
Girard Partners's Prothena Corp position peaked at $6K in Q3 2018.
120 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.